Effect of spironolactone wash‐out on albuminuria after long‐term treatment in individuals with type 2 diabetes and high risk of kidney disease—An observational follow‐up of the <scp>PRIORITY</scp> study
UACR did not change after discontinuation of long-term treatment with spironolactone. However, an increase in eGFR was observed supporting a haemodynamic effect of spironolactone in the kidneys.
Authors
- Frederik Persson (ORCID: https://orcid.org/0000-0001-6242-6638)
- Marie Frimodt‐Møller (ORCID: https://orcid.org/0000-0002-8486-1515)
- Tine W. Hansen (ORCID: https://orcid.org/0000-0003-2274-0352)
- Gemma Currie (ORCID: https://orcid.org/0000-0002-0797-0224)
- Christian Delles (ORCID: https://orcid.org/0000-0003-2238-2612)
- Harald Mischak (ORCID: https://orcid.org/0000-0003-0323-0306)
- Thomas Kümler (ORCID: https://orcid.org/0000-0001-9102-3862)
- Viktor Rotbain Curovic (ORCID: https://orcid.org/0000-0002-4270-6701)
- Morten Lindhardt (ORCID: https://orcid.org/0000-0001-6063-1718)
- Nete Tofte (ORCID: https://orcid.org/0000-0002-5331-9168)
- Peter R Rossing (ORCID: https://orcid.org/0000-0002-1531-4294)
- Victor Wasehuus (ORCID: https://orcid.org/0000-0003-1822-8188)
- Heiko von der Leyen
Institutions
- University of Copenhagen (DK)
- Steno Diabetes Centers (DK)
- Mosaiques Diagnostics and Therapeutics (Germany) (DE)
- Holbæk Sygehus (DK)
- University of Glasgow (GB)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2024-10-28
- DOI
- https://doi.org/10.1111/dom.16037
- Citations
- 1
- Primary Topic
- Electrolyte and hormonal disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.42
Funders
- European Commission
- Seventh Framework Programme